Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
07/2003
07/03/2003US20030126647 Method for inducing seed development by down-regulating expression of the FIS2 gene
07/03/2003US20030126645 Expression vectors for modifying oil and size phenotypes; genetic mapping variation in crop plants
07/03/2003US20030126643 Manipulation of cellulose and/or beta-1,4-glucan
07/03/2003US20030126640 Genes for plant fatty acid modifying enzymes associated with conjugated double bond formation
07/03/2003US20030126637 Conferring antiviral, bactericidal and fungicidal infection activity monocotyledonous plants
07/03/2003US20030126636 Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use
07/03/2003US20030126633 Genetically engineered potato which produces increased concentration of glucans/polysaccharides through antisense inhibition of branching enzymes and R1 protein
07/03/2003US20030126628 Avian oviduct regulatory sequences for controlling expression of interferon in transgenic cells; bioreactors
07/03/2003US20030126626 Rodent model which cultures human liver cells for regeneration of tissues, providing alternative to liver transplantation; side effect reduction; drug screening
07/03/2003US20030126624 Chimeric DNA-binding proteins
07/03/2003US20030125782 Methods for the regeneration of bone and cartilage
07/03/2003US20030125615 Homing of autologous cells to a target zone in tissue using active therapeutics or substances
07/03/2003US20030125537 Neovascularization; platelet derived growth factors; vascular permeability factors; wound healing agents; antitumor/antiproliferative agents; antisense agents; for treatment of intestinal malabsorption syndrome
07/03/2003US20030125536 Fusion proteins/antigen presenting cells for promoting expansion of lymphocytes; vaccines
07/03/2003US20030125535 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/03/2003US20030125534 Nucleotide sequences coding hydrolases for use in cleaning agents, detergents, textile treatment, baking, inking recycled paper, animal feeds, beverages and in the oilfield industry
07/03/2003US20030125533 Regulation of human sphingosine kinase-like protein
07/03/2003US20030125523 Novel neuropilin/growth factor complexes and uses thereof
07/03/2003US20030125522 Novel peptides conferring environmental stress resistance and fusion proteins including said peptides
07/03/2003US20030125521 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
07/03/2003US20030125519 Ligand for the c-kit receptor and methods of use thereof
07/03/2003US20030125293 Cell culture product for the treatment and repair of eye vision defects
07/03/2003US20030125287 Antisense oligonucleotides and methods to induce tumor cell death
07/03/2003US20030125282 Treating fertility disorders; maternal-antigen-that-embryos-require (MATER)
07/03/2003US20030125273 Antisense modulation of MHC class II transactivator expression
07/03/2003US20030125262 Methods and reagents for regulation of cellular responses in biological systems
07/03/2003US20030125248 Novel bone mineralization proteins, DNA, vectors expression systems
07/03/2003US20030125247 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein
07/03/2003US20030125246 Respiratory system related polynucleotides and the polypeptides encoded by these polynucleotides known as respiratory system antigens useful for detecting cancer or cancer metastases of respiratory system tissues
07/03/2003US20030125232 Stabilized proteins with engineered disulfide bonds
07/03/2003US20030124724 Genetically engineering plants to produce starch with increased amylopectin concentration; auxins; antisense agents; animal feeds; cosmetics; papermaking
07/03/2003US20030124722 Chamber for artificial organ
07/03/2003US20030124721 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
07/03/2003US20030124720 Conditioned culture media
07/03/2003US20030124719 Isolating target populations of tissues from fluids; immunotherapy; enzyme inhibitor
07/03/2003US20030124718 Cytolytic T lymphocyte (CTL); viricides; particle acceleration apparatus
07/03/2003US20030124716 Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof
07/03/2003US20030124704 Neuroprotectants; inhibition of axonal growth; antitumor agents
07/03/2003US20030124695 Genes encoding baeyer-villiger monooxygenases
07/03/2003US20030124677 Amino-terminally truncated MCP-2 as chemokine antagonists
07/03/2003US20030124675 Isolated CDNA encoding tumor necrosis factor binding protein II, its purification, and vectors, hosts and processes using such cDNA
07/03/2003US20030124668 Plasmid for use in gene expression, mapping and mutagenesis; transposases
07/03/2003US20030124667 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/03/2003US20030124663 Membrane proteins; antiproliferative agents; antitumor agents; antisense agents; neovascularization
07/03/2003US20030124662 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/03/2003US20030124658 Molecular display on multmeric protein scaffolds derived from the e2 component of the alphaketoacid dehydrogenase
07/03/2003US20030124655 Receptor protein specifically recognizing bacterial dna
07/03/2003US20030124650 Isolating streptomyces serine proteases using immunoaffinity chromatography; oligopeptides
07/03/2003US20030124649 Membrane associated proteins
07/03/2003US20030124648 Vector/plasmid for efficient and accurate transfer of preferential gene to rodent cells; glutamine synthetases
07/03/2003US20030124641 Method for identifying endocrine disruptors and kit for carrying out the same
07/03/2003US20030124626 Method of screening antiplatelet
07/03/2003US20030124602 Tumour suppresor and uses thereof
07/03/2003US20030124598 PGC-1beta, a novel PGC-1 homologue and uses therefor
07/03/2003US20030124596 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874
07/03/2003US20030124587 Human tyrosine-DNA phosphodiesterase variant polypeptides and methods of use therefor
07/03/2003US20030124582 Polypeptide encoded by a polynucleotide of given sequence; detecting the effect of a test compound on the production of mRNA; use in identifying agonists/antagonists that may be useful in therapy
07/03/2003US20030124575 Dendritic cells; antigen presenting cells; g-protein coupled receptors; immunotherapy; antiinflammatory agents; antitumor agents; viricides; drug screening
07/03/2003US20030124563 Immunohistochemistry; tumor diagnosis; antitumor agents; anticarcinogenic agents; tissue engineering; ki-67 proteins
07/03/2003US20030124561 Plant centromere compositions
07/03/2003US20030124559 Rna polymerases from bacteriophage phi 6-phI 14 and use thereof
07/03/2003US20030124555 Compositions and methods for use in isolation of nucleic acid molecules
07/03/2003US20030124534 Measuring expression of nucleotide sequences in cells
07/03/2003US20030124531 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/03/2003US20030124529 Pregnancy-associated plasma protein-A2 (PAPP-A2)
07/03/2003US20030124520 Methods for identifying agents that cause a lethal phenotype, and agents thereof
07/03/2003US20030124517 Hepatitis A virus nucleotide sequences, recombinant proteins and uses thereof
07/03/2003US20030124516 Method of using optical interrogation to determine a biological property of a cell or population of cells
07/03/2003US20030124173 Manufacturing therapeutic enclosures
07/03/2003US20030124169 Biocompatible, biodegradable matrix and a protein, produced by expression of recombinant DNA capable of inducing endochondral bone formation in association with said matrix
07/03/2003US20030124168 Base material for tissue reconstruction, implantable material, and methods of preparing the same
07/03/2003US20030124138 Endogenous activating ligand which is a potentially important neuroregulator.
07/03/2003US20030124136 Immunotherapy for reversing immune suppression
07/03/2003US20030124129 Angiopoietin-2 specific binding agents
07/03/2003US20030124125 Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10
07/03/2003US20030124123 Also an IL-12 anti-idiotype antibody to the antibody
07/03/2003US20030124122 Simultaneous stimulation and concentration of cells
07/03/2003US20030124116 Antibodies binding to polypeptides encoded by the genes
07/03/2003US20030124114 Genes that encode cell surface molecules with conserved IgV and mucin domains; diagnosis or staging of cancer; treatment of an immunological disorder; detecting a predisposition to asthma
07/03/2003US20030124113 Human apoptosis associated proteins
07/03/2003US20030124108 Useful in wound healing, autoimmune disorders and inflammatory diseases
07/03/2003US20030124107 PAK5-related compositions and methods
07/03/2003US20030124105 Programmed cell death genes and proteins
07/03/2003US20030124103 Tumor cells with increased immunogenicity and uses therefor
07/03/2003US20030124102 Differentiating adult pluripotent stem cells to produce myoblasts
07/03/2003US20030124100 Includes an endothelial specific enhancer element; especially modifications of the PPE promoter, which enhance its expression in response to hypoxia and angiogenesis.
07/03/2003US20030124099 Three-dimensional biomatrix formed by perfusing a matrix material with cultured cells that attach to the matrix material and produce a tissue layer capable of augmenting organ function
07/03/2003US20030124092 IL-17 like molecules and uses thereoflike molecules and uses thereof
07/03/2003US20030124091 Administration of the factor with a vaccine to enhance immune response
07/03/2003US20030124060 Purified linear epitopes from cashew nuts, nucleic acids encoding therefor, and associated methods
07/03/2003CA2849201A1 Adipose-derived cell processing unit
07/03/2003CA2803931A1 Methods for producing hyaluronan in a recombinant host cell
07/03/2003CA2643133A1 Automated system and method for processing specimens to extract samples for both liquid-based and slide-based testing
07/03/2003CA2486930A1 Anti-tirc7 antibodies in therapy of inflammatory diseases
07/03/2003CA2486689A1 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases
07/03/2003CA2471369A1 Glycosyl hydrolases obtained from metagenomic analysis
07/03/2003CA2471160A1 Seminal vesicle tissue-specific promoters and uses thereof
07/03/2003CA2471140A1 Antibodies that immunospecifically bind to trail receptors
07/03/2003CA2470943A1 Forming and modifying dielctrically-engineered microparticles
07/03/2003CA2470844A1 Novel compositions and methods for cancer
1 ... 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 ... 1827